Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.36 |
| ▸ | BTK | Q06187 | 2/20 | 0.36 |
| ▸ | LPL | P06858 | 2/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21888321 | 0.86 | KDM4E (0.33) | JAK2BTKLPLLIPGCRHBP | |
| SCHEMBL22328871 | 0.85 | LPL (0.43) | JAK2BTKLPLLIPGCRHBP | |
| SCHEMBL30169934 | 0.84 | LIPG (0.42) | LPLLIPGCRHBPCRHR2KEAP1 | |
| SCHEMBL762751 | 0.84 | LIPG (0.42) | LPLLIPGCRHBPCRHR2KEAP1 | |
| SCHEMBL21888323 | 0.84 | LPL (0.34) | JAK2BTKLPLLIPG | |
| SCHEMBL21888373 | 0.82 | LPL (0.38) | LPLLIPG | |
| SCHEMBL30040842 | 0.82 | KEAP1 (0.46) | JAK2BTKLPLLIPGCRHBP | |
| SCHEMBL961673 | 0.82 | KEAP1 (0.46) | JAK2BTKLPLLIPGCRHBP | |
| SCHEMBL29709221 | 0.82 | KEAP1 (0.46) | JAK2BTKLPLLIPGCRHBP | |
| SCHEMBL21888372 | 0.81 | JAK2 (0.40) | JAK2BTKLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200255358-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255358-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNL2, MCM4, CCNT1 | JAK2 1830/4885BTK 3827/4885LPL 3322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.